Crosslinked Hyaluronic Acid Gel for Dermal Filler Injection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current injectable treatments for improving skin quality, particularly for fine lines and wrinkles, require multiple sessions and have a short duration of effect, making them inconvenient and less effective in maintaining long-term skin improvement.

Innovation Solution

Development of hyaluronic acid (HA) based compositions with a crosslinked HA matrix using low molecular weight HA and a combination of low and high molecular weight HA, which are easier to inject through a thin needle and provide extended duration of effect, typically lasting several months to a year with a single treatment session.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If HA-based dermal fillers have high viscosity (highly crosslinked, high molecular weight, high HA concentration), then duration of effect is extended, but injection difficulty increases requiring lower gauge needles

Engineering Contradiction:
Improveduration of effectVSAvoidinjection difficulty
Core Design Contradiction:
Duration of action of moving objectVSEase of operation

Solution Approach 1:

The patent changes the molecular weight parameter of HA from high to low (below 1 MDa) while adjusting crosslinking degree and HA concentration to achieve the desired balance between injectability and duration of effect

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite gel structure by crosslinking low molecular weight HA with specific crosslinking agents (BDDE, BGG, or BG) to form a network that provides both ease of injection and extended duration of effect

Inventive Principle:
Principle #40Composite materials

2Ease of operation

If HA-based dermal fillers have low viscosity (lightly crosslinked, low molecular weight, low HA concentration), then injection is easier through high gauge needles, but duration of effect is shortened

Engineering Contradiction:
Improveinjection easeVSAvoidduration of effect
Core Design Contradiction:
Ease of operationVSDuration of action of moving object

Solution Approach 1:

The patent optimizes the crosslinking degree parameter to a specific range (0.1% to 20% w/w crosslinking agent relative to HA) that maintains low viscosity for easy injection while ensuring sufficient duration of effect (at least 3 months)

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent applies different properties to different aspects of the HA gel: low molecular weight for overall low viscosity and ease of injection, while localized crosslinking provides structural integrity and extended duration of effect

Inventive Principle:
Principle #3Local quality

3Reliability

If multiple treatment sessions are administered every three to four weeks, then skin quality improvement is achieved, but treatment time and inconvenience increase

Engineering Contradiction:
Improveskin quality improvementVSAvoidtreatment time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent extends the duration of useful action of the dermal filler to at least 3 months, allowing a single treatment session to provide continuous skin quality improvement without requiring repeated injections every 3-4 weeks

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The HA-based compositions effectively improve skin texture, hydration, and elasticity, reducing the need for repeated treatments and providing sustained skin improvement for several months to a year, enhancing skin appearance and quality.

Implementation Method 1

Hyaluronic acid is a naturally occurring, water soluble polysaccharide... HA has the ability to bind to large amounts of water

Methodology Applied
Scientific EffectHydrogen bonding: Chemical Bonding

Data Source

PatentUS20240307289A1Compositions and methods for improving skin appearance
Publication Date: 2024.09.19 ALLERGAN INDUSTRIE SAS
  • US20240307289A1 patent drawing
  • US20240307289A1 patent drawing
  • US20240307289A1 patent drawing

AI summary

Injectable compositions and methods of treating skin can help improve hydration, elasticity and/or texture of the skin. The compositions can be based on crosslinked hyaluronic acid matrices made with low molecular weight hyaluronic acids.